Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-004588
Filing Date
2023-10-23
Accepted
2023-10-23 16:06:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4016
  Complete submission text file 0001950047-23-004588.txt   5380
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37581 | Film No.: 231340065
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACLARIS THERAPEUTICS, INC. 640 LEE ROAD, SUITE 200 WAYNE PA 19087
Business Address
Monahan Joseph (Reporting) CIK: 0001861790 (see all company filings)

Type: 144